Compare Multi Bintang Indonesia Tbk. (MLBI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multi Bintang Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Multi Bintang Indonesia Tbk. trades at Rp6,800 (market cap 14.38T, 58.9K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Multi Bintang Indonesia Tbk. is far larger — about 137.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| MLBI | SCPI | |
|---|---|---|
Market Cap | 14.38T | 104.4B |
Volume | 58.9K | — |
Lot | 589 | — |
Turnover | 400.52M | — |
Average Price | 6,799.92 | — |
Value | 400.52M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multi Bintang Indonesia Tbk.
PT Multi Bintang Indonesia Tbk (The Company) was established on June 3, 1929, based on notarial deed No. 8 of Tjeerd Dijkstra, notary public in Medan, under the name of NV Nederlandsch Indische Bierbrouwerijen. The Company is part of the Heineken Group, where the ultimate shareholder is Heineken N.V. (Heineken).
Read more on MLBI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
